S2Medical AB (publ) (STO:S2M)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.0116
-0.0004 (-3.33%)
Oct 30, 2025, 9:40 AM CET

S2Medical AB Company Description

S2Medical AB (publ) develops products for wound healing, infection control, and cosmeceuticals spectrum in Sweden.

The company offers odor eliminator under the YNOLENS brand; IvaQ, a negative pressure wound therapy (NPWT) system; Instagraft, a technology designed to make skin transplantation even in non-specialist healthcare setting; ADMERCIN, a solution against antibiotic-resistant bacteria; and Epiprotect, a technology designed to protect and support wound healing by creating an environment for tissue recovery.

It also provides Symbiovance, a peptide-based functional skincare; Eyracure, a light-activated peptide technology that repairs damaged hair at the molecular level; and Eiratex, a biosynthetic polymer for wound healing applications.

In addition, the company distributes instaQrett; skin substitutes under the EPIPROTECT brand; and BIOPAD, an ivory-white soft sponge.

The company was incorporated in 2013 and is headquartered in Linköping, Sweden.

S2Medical AB (publ)
CountrySweden
Founded2013
IndustryMedical Instruments & Supplies
SectorHealthcare
Employees7
CEOPetter Sivler

Contact Details

Address:
Sunnorpsgatan 5
Linköping, 582 73
Sweden
Phone46 87 00 00 50
Websites2m.se

Stock Details

Ticker SymbolS2M
ExchangeNasdaq Stockholm
Share ClassClass B Shares
Fiscal YearJanuary - December
Reporting CurrencySEK
ISIN NumberSE0011725084
SIC Code3842

Key Executives

NamePosition
Petter SivlerCo-Founder and Chief Executive Officer
Marten SkogCo-Founder, Chief Operating Officer and Director